STAT

It’s just in mice! This scientist is calling out hype in science reporting

This scientist smells a rat: As @justsaysinmice on Twitter, James Heathers is calling out hyped reports of mouse studies.

Mice form the basis of all biomedical research. As the quintessential model organism, they are perfect specimens in which to study all sorts of human conditions. But just because a drug performs well in mice, that doesn’t necessarily mean it’ll have the same result in humans. Science journalists and press releases — as translators of these findings — often fail to clearly demarcate that line.

A new Twitter account hopes to make that line much clearer. Last Friday, tweets from started making the rounds on Twitter and they quickly went viral. Every tweet — all 11 of them so far — follows the same pattern: A news story or press release with a

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks